Sort
40,608 grants matching “prostate cancer”
Tumor and Circulating Markers as Links Between Obesity and Lethal Prostate Cance
$336,247Lorelei Mucci · Dana-Farber Cancer Inst · P50 · FY2016 · CA
POST-EXERCISE ION CHANNEL GENE EXPRESSION BIOMARKERS IN CFS
$336,188Kathleen C Light · University Of Utah · R01 · FY2012 · AR
Prostate cancer prevention and treatment by sillibinin
$336,180University Of Colorado Denver · R01 · FY2003 · CA
Phototherapy of Prostate Cancer-Pro and Anti Apoptosis
$336,161Nancy L Oleinick · Case Western Reserve University · R01 · FY2006 · CA
Phosphodiesterase 10A, a novel target for lung cancer chemoprevention
$336,158Gary A Piazza · University Of South Alabama · R01 · FY2019 · CA
Role of TOP2B in generating complex genomic rearrangements in human cancer
$336,150Srinivasan Yegnasubramanian · Johns Hopkins University · R01 · FY2017 · CA
Role of TOP2B in generating complex genomic rearrangements in human cancer
$336,150Srinivasan Yegnasubramanian · Johns Hopkins University · R01 · FY2014 · CA
Role of TOP2B in generating complex genomic rearrangements in human cancer
$336,150Srinivasan Yegnasubramanian · Johns Hopkins University · R01 · FY2018 · CA
Role of TOP2B in generating complex genomic rearrangements in human cancer
$336,150Srinivasan Yegnasubramanian · Johns Hopkins University · R01 · FY2016 · CA
Role of TOP2B in generating complex genomic rearrangements in human cancer
$336,150Srinivasan Yegnasubramanian · Johns Hopkins University · R01 · FY2015 · CA
Prostate cancer prevention by selenium supplementation
$336,150Rayudu Gopalakrishna · University Of Southern California · R01 · FY2010 · CA
STAT1 Activation and HPP1 Tumor Suppression
$336,129David Shibata · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2012 · CA
STAT1 Activation and HPP1 Tumor Suppression
$336,129David Shibata · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2011 · CA
Hedgehog Pathway Blockade by Small-Molecule Gli Antagonists
$336,123James K Chen · Stanford University · R01 · FY2009 · CA
Project 2 - Fatty Liver Predisposes to Metastasis: Role of Hepatic Stellate Cells
$336,117Ekihiro Seki · Cedars-Sinai Medical Center · P01 · FY2021 · CA
Anticarcinogenic Effect of ITCs Against Prostate Cancer
$336,105Shivendra Singh · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · CA
Evaluation of CYP24 as a Target for Enhancing Vitamin D*
$336,100Donald L Trump · Roswell Park Cancer Institute Corp · R21 · FY2006 · CA
Toward Selective Androgen Deprivation by Targeting Androgen Activation of SRF
$336,071Hannelore Heemers · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · CA
Core 1: Integrated Pathology and Radiology Core (iPRC)
$336,043Wei Huang · University Of Wisconsin-Madison · P50 · FY2024 · CA
Biomarker screening algorithms for the improved early detection of hepatocellular carcinoma
$336,024Nabihah Tayob · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
Clinical Radiation Physics Service
$336,024Robert Miller · Division Of Clinical Sciences - Nci · ZID · FY2024 · CA
Project 3: Developing CAR T Cell Therapies to Target Tumor Heterogeneity in Advanced Prostate Cancer
$336,009Owen N Witte · University Of California Los Angeles · P50 · FY2022 · CA
Molecular mechanism of Androgen Receptor mediated transcription
$336,000Zhao Wang · Baylor College Of Medicine · R01 · FY2025 · GM
Molecular mechanism of Androgen Receptor mediated transcription
$336,000Zhao Wang · Baylor College Of Medicine · R01 · FY2021 · GM
Molecular mechanism of Androgen Receptor mediated transcription
$336,000Zhao Wang · Baylor College Of Medicine · R01 · FY2024 · GM